Edaravone ameliorates oxidative stress associated cholinergic dysfunction and limits apoptotic response following focal cerebral ischemia in rat

Ajmal Ahmad, Mohd Moshahid Khan, Hayate Javed, Syed Shadab Raza, Tauheed Ishrat, Mohammad Badruzzaman Khan, Mohammed M. Safhi, Fakhrul Islam

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Stroke is a life-threatening disease with major cause of mortality and morbidity worldwide. The neuronal damage following cerebral ischemia is a serious risk to stroke patients. Oxidative stress and apoptotic damage play an important role in cerebral ischemic pathogenesis and may represent a target for treatment. The objective of this study was to test the hypothesis that administration of edaravone (Edv) maintains antioxidant status in brain, improves the cholinergic dysfunction and suppresses the progression of apoptosis response in rat. To test this hypothesis, male Wistar rats were subjected to middle cerebral artery occlusion (MCAO) of 2 h followed by reperfusion for 22 h. Edv was administered (10 mg/kg bwt) intraperitoneally 30 min before the onset of ischemia and 1 h after reperfusion. After reperfusion, rats were tested for neurobehavioral activities and were sacrificed for the infarct volume, estimation of oxidative damage markers. Edv treatment significantly reduced ischemic lesion volume, improved neurological deficits, contended oxidative loads, and suppressed apoptotic damage. In conclusion, treatment with Edv ameliorated the neurological and histological outcomes with elevated endogenous anti-oxidants status as well as reduced induction of apoptotic responses in MCA occluded rat. We theorized that Edv is among the pharmacological agents that reduce free radicals and its associated cholinergic dysfunction and apoptotic damage and have been found to limit the extent of brain damage following stroke.

Original languageEnglish (US)
Pages (from-to)215-225
Number of pages11
JournalMolecular and Cellular Biochemistry
Volume367
Issue number1-2
DOIs
StatePublished - Aug 1 2012
Externally publishedYes

Fingerprint

Oxidative stress
Brain Ischemia
Cholinergic Agents
Rats
Oxidative Stress
Reperfusion
Stroke
Brain
Middle Cerebral Artery Infarction
Oxidants
Free Radicals
Wistar Rats
Therapeutics
Ischemia
Antioxidants
phenylmethylpyrazolone
Pharmacology
Apoptosis
Morbidity
Mortality

Keywords

  • Antioxidant
  • Apoptosis
  • Cerebral ischemia
  • Neuroprotection
  • Oxidative stress

ASJC Scopus subject areas

  • Molecular Biology
  • Clinical Biochemistry
  • Cell Biology

Cite this

Edaravone ameliorates oxidative stress associated cholinergic dysfunction and limits apoptotic response following focal cerebral ischemia in rat. / Ahmad, Ajmal; Moshahid Khan, Mohd; Javed, Hayate; Raza, Syed Shadab; Ishrat, Tauheed; Khan, Mohammad Badruzzaman; Safhi, Mohammed M.; Islam, Fakhrul.

In: Molecular and Cellular Biochemistry, Vol. 367, No. 1-2, 01.08.2012, p. 215-225.

Research output: Contribution to journalArticle

Ahmad, Ajmal ; Moshahid Khan, Mohd ; Javed, Hayate ; Raza, Syed Shadab ; Ishrat, Tauheed ; Khan, Mohammad Badruzzaman ; Safhi, Mohammed M. ; Islam, Fakhrul. / Edaravone ameliorates oxidative stress associated cholinergic dysfunction and limits apoptotic response following focal cerebral ischemia in rat. In: Molecular and Cellular Biochemistry. 2012 ; Vol. 367, No. 1-2. pp. 215-225.
@article{75c7e41f0a4946ed94ae990dbf4bb78f,
title = "Edaravone ameliorates oxidative stress associated cholinergic dysfunction and limits apoptotic response following focal cerebral ischemia in rat",
abstract = "Stroke is a life-threatening disease with major cause of mortality and morbidity worldwide. The neuronal damage following cerebral ischemia is a serious risk to stroke patients. Oxidative stress and apoptotic damage play an important role in cerebral ischemic pathogenesis and may represent a target for treatment. The objective of this study was to test the hypothesis that administration of edaravone (Edv) maintains antioxidant status in brain, improves the cholinergic dysfunction and suppresses the progression of apoptosis response in rat. To test this hypothesis, male Wistar rats were subjected to middle cerebral artery occlusion (MCAO) of 2 h followed by reperfusion for 22 h. Edv was administered (10 mg/kg bwt) intraperitoneally 30 min before the onset of ischemia and 1 h after reperfusion. After reperfusion, rats were tested for neurobehavioral activities and were sacrificed for the infarct volume, estimation of oxidative damage markers. Edv treatment significantly reduced ischemic lesion volume, improved neurological deficits, contended oxidative loads, and suppressed apoptotic damage. In conclusion, treatment with Edv ameliorated the neurological and histological outcomes with elevated endogenous anti-oxidants status as well as reduced induction of apoptotic responses in MCA occluded rat. We theorized that Edv is among the pharmacological agents that reduce free radicals and its associated cholinergic dysfunction and apoptotic damage and have been found to limit the extent of brain damage following stroke.",
keywords = "Antioxidant, Apoptosis, Cerebral ischemia, Neuroprotection, Oxidative stress",
author = "Ajmal Ahmad and {Moshahid Khan}, Mohd and Hayate Javed and Raza, {Syed Shadab} and Tauheed Ishrat and Khan, {Mohammad Badruzzaman} and Safhi, {Mohammed M.} and Fakhrul Islam",
year = "2012",
month = "8",
day = "1",
doi = "10.1007/s11010-012-1335-6",
language = "English (US)",
volume = "367",
pages = "215--225",
journal = "Molecular and Cellular Biochemistry",
issn = "0300-8177",
publisher = "Springer Netherlands",
number = "1-2",

}

TY - JOUR

T1 - Edaravone ameliorates oxidative stress associated cholinergic dysfunction and limits apoptotic response following focal cerebral ischemia in rat

AU - Ahmad, Ajmal

AU - Moshahid Khan, Mohd

AU - Javed, Hayate

AU - Raza, Syed Shadab

AU - Ishrat, Tauheed

AU - Khan, Mohammad Badruzzaman

AU - Safhi, Mohammed M.

AU - Islam, Fakhrul

PY - 2012/8/1

Y1 - 2012/8/1

N2 - Stroke is a life-threatening disease with major cause of mortality and morbidity worldwide. The neuronal damage following cerebral ischemia is a serious risk to stroke patients. Oxidative stress and apoptotic damage play an important role in cerebral ischemic pathogenesis and may represent a target for treatment. The objective of this study was to test the hypothesis that administration of edaravone (Edv) maintains antioxidant status in brain, improves the cholinergic dysfunction and suppresses the progression of apoptosis response in rat. To test this hypothesis, male Wistar rats were subjected to middle cerebral artery occlusion (MCAO) of 2 h followed by reperfusion for 22 h. Edv was administered (10 mg/kg bwt) intraperitoneally 30 min before the onset of ischemia and 1 h after reperfusion. After reperfusion, rats were tested for neurobehavioral activities and were sacrificed for the infarct volume, estimation of oxidative damage markers. Edv treatment significantly reduced ischemic lesion volume, improved neurological deficits, contended oxidative loads, and suppressed apoptotic damage. In conclusion, treatment with Edv ameliorated the neurological and histological outcomes with elevated endogenous anti-oxidants status as well as reduced induction of apoptotic responses in MCA occluded rat. We theorized that Edv is among the pharmacological agents that reduce free radicals and its associated cholinergic dysfunction and apoptotic damage and have been found to limit the extent of brain damage following stroke.

AB - Stroke is a life-threatening disease with major cause of mortality and morbidity worldwide. The neuronal damage following cerebral ischemia is a serious risk to stroke patients. Oxidative stress and apoptotic damage play an important role in cerebral ischemic pathogenesis and may represent a target for treatment. The objective of this study was to test the hypothesis that administration of edaravone (Edv) maintains antioxidant status in brain, improves the cholinergic dysfunction and suppresses the progression of apoptosis response in rat. To test this hypothesis, male Wistar rats were subjected to middle cerebral artery occlusion (MCAO) of 2 h followed by reperfusion for 22 h. Edv was administered (10 mg/kg bwt) intraperitoneally 30 min before the onset of ischemia and 1 h after reperfusion. After reperfusion, rats were tested for neurobehavioral activities and were sacrificed for the infarct volume, estimation of oxidative damage markers. Edv treatment significantly reduced ischemic lesion volume, improved neurological deficits, contended oxidative loads, and suppressed apoptotic damage. In conclusion, treatment with Edv ameliorated the neurological and histological outcomes with elevated endogenous anti-oxidants status as well as reduced induction of apoptotic responses in MCA occluded rat. We theorized that Edv is among the pharmacological agents that reduce free radicals and its associated cholinergic dysfunction and apoptotic damage and have been found to limit the extent of brain damage following stroke.

KW - Antioxidant

KW - Apoptosis

KW - Cerebral ischemia

KW - Neuroprotection

KW - Oxidative stress

UR - http://www.scopus.com/inward/record.url?scp=84863477537&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863477537&partnerID=8YFLogxK

U2 - 10.1007/s11010-012-1335-6

DO - 10.1007/s11010-012-1335-6

M3 - Article

C2 - 22648734

AN - SCOPUS:84863477537

VL - 367

SP - 215

EP - 225

JO - Molecular and Cellular Biochemistry

JF - Molecular and Cellular Biochemistry

SN - 0300-8177

IS - 1-2

ER -